Oaktree Capital Management’s Arbor Rapha Capital Bioholdings Corp. I Class A Common Stock ARCK Stock Holding History

Oaktree Capital Management’s Portfolio ARCK Stock Details ARCK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-100,000	Closed	-$1.01M	–	382
2022 Q3	$1.01M	Hold	100,000	–	–	0.01%	331
2022 Q2	$1M	Hold	100,000	–	–	0.01%	314
2022 Q1	$1M	Hold	100,000	–	–	0.01%	304
2021 Q4	$995K	Buy	+100,000	New	+$992K	0.01%	301

Other funds holding ARCK

WAM

Wolverine Asset Management Chicago, Illinois $10.4B AUM 4.78% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Oaktree Capital Management's ARCK Position: Q4 2022 in Review

Oaktree Capital Management sold out of Arbor Rapha Capital Bioholdings Corp. I Class A Common Stock (ARCK) in Q4 2022, closing a stake of 100,000 shares — an estimated $1.01M sold.

Oaktree Capital Management first reported a position in ARCK in Q4 2021 and held it in 4 quarters. The position peaked at $1.01M in Q3 2022. 2 funds tracked by Wall St. Rank hold ARCK as of Q4 2022.

Oaktree Capital Management reported no remaining Arbor Rapha Capital Bioholdings Corp. I Class A Common Stock position as of Q4 2022 after selling out during the quarter.
Oaktree Capital Management sold 100,000 Arbor Rapha Capital Bioholdings Corp. I Class A Common Stock shares in Q4 2022, an estimated $1.01M.
Oaktree Capital Management first reported a position in Arbor Rapha Capital Bioholdings Corp. I Class A Common Stock in Q4 2021 and held it in 4 quarters.
Oaktree Capital Management's Arbor Rapha Capital Bioholdings Corp. I Class A Common Stock position peaked at $1.01M in Q3 2022.
2 funds tracked by Wall St. Rank held Arbor Rapha Capital Bioholdings Corp. I Class A Common Stock as of Q4 2022.

Based on Oaktree Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.